Expression Table for this CRE
| CNhs12200 | Dendritic Cells - plasmacytoid, donor3 | 6.2 |
| CNhs12082 | Fibroblast - Lymphatic, donor2 | 5.8 |
| CNhs12925 | Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1) | 5.0 |
| CNhs11990 | Smooth Muscle Cells - Subclavian Artery, donor2 | 4.3 |
| CNhs12667 | MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2 | 3.7 |
| CNhs12652 | MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2 | 3.5 |
| CNhs12473 | K562 erythroblastic leukemia response to hemin, day03, biol_rep1 | 3.2 |
| CNhs11763 | uterus, fetal, donor1 | 3.1 |
| CNhs14494 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1 | 3.0 |
| CNhs12004 | Smooth Muscle Cells - Brain Vascular, donor3 | 2.8 |
| CNhs12120 | Renal Proximal Tubular Epithelial Cell, donor3 | 2.8 |
| CNhs12491 | MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2 | 2.8 |
| CNhs12181 | CD19+ B Cells (pluriselect), donor090309, donation3 | 2.6 |
| CNhs11886 | chronic myeloblastic leukemia (CML) cell line:KCL-22 | 2.6 |
| CNhs11779 | diaphragm, fetal, donor1 | 2.4 |
| CNhs14080 | locus coeruleus, newborn, donor10223 | 2.3 |
| CNhs12094 | Corneal Epithelial Cells, donor2 | 2.3 |
| CNhs13836 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1 | 2.2 |
| CNhs11987 | Smooth Muscle Cells - Coronary Artery, donor2 | 2.2 |
| CNhs11757 | heart, adult, diseased post-infarction, donor1 | 2.1 |
| CNhs12547 | Eosinophils, donor1 | 2.0 |
| CNhs11988 | Smooth Muscle Cells - Internal Thoracic Artery, donor2 | 1.9 |
| CNhs12498 | Fibroblast - Cardiac, donor1 | 1.9 |
| CNhs12395 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14) | 1.8 |
| CNhs11959 | Neutrophils, donor2 | 1.7 |
| CNhs11830 | peripheral neuroectodermal tumor cell line:KU-SN | 1.7 |
| CNhs12075 | Hepatic Sinusoidal Endothelial Cells, donor1 | 1.7 |
| CNhs13841 | iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2 | 1.6 |
| CNhs11930 | clear cell carcinoma cell line:TEN | 1.5 |
| CNhs11891 | hereditary spherocytic anemia cell line:WIL2-NS | 1.5 |
| CNhs13337 | mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1 | 1.5 |
| CNhs11872 | thyroid carcinoma cell line:TCO-1 | 1.5 |
| CNhs12427 | MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1 | 1.4 |
| CNhs14588 | Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1 | 1.4 |
| CNhs14558 | Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction) | 1.4 |
| CNhs11716 | papillary adenocarcinoma cell line:8505C | 1.4 |
| CNhs13397 | Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2) | 1.3 |
| CNhs11766 | trachea, fetal, donor1 | 1.3 |
| CNhs12654 | MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2 | 1.3 |
| CNhi10939_ACC | Human primary dermal lymphatic vascular endothelial cells, biol_rep1 | 1.3 |
| CNhs14532 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1 | 1.3 |
| CNhs12920 | Fibroblast - Villous Mesenchymal, donor3 | 1.2 |
| CNhs12530 | neutrophil PMN, donor3 | 1.2 |
| CNhs14499 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3 | 1.2 |
| CNhs12700 | K562 erythroblastic leukemia response to hemin, day02, biol_rep2 | 1.2 |
| CNhs14600 | Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2 | 1.2 |
| CNhs11873 | mucinous cystadenocarcinoma cell line:MCAS | 1.2 |
| SRX18306686 | wild type_treated with DMSO and ethanol_2 h, rep1 | 1.2 |
| CNhs11957 | Natural Killer Cells, donor2 | 1.1 |
| CNhs11945 | meningioma cell line:HKBMM | 1.1 |